These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 5107821

  • 1. [Clinical effect of L-DOPA and electromyographic study of Parkinsonism].
    Sato G, Ito H, Handa Y, Takahashi I, Iijima K.
    No To Shinkei; 1971 Mar; 23(3):325-32. PubMed ID: 5107821
    [No Abstract] [Full Text] [Related]

  • 2. [Clinical experience with L-DOPA in the treatment of parkinsonism].
    Chiba T.
    No To Shinkei; 1970 Dec; 22(12):1399-405. PubMed ID: 5536833
    [No Abstract] [Full Text] [Related]

  • 3. [L-dopa and Parkinson's disease].
    Barbeau A.
    Union Med Can; 1970 Dec; 99(12):2195-7. PubMed ID: 5488646
    [No Abstract] [Full Text] [Related]

  • 4. [Treatment of parkinsonism with L-dopa].
    Court J, Kase JC, Palacios E, Mena I.
    Rev Med Chil; 1971 Jun; 99(6):399-401. PubMed ID: 5561157
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical study of L-dopa in Parkinson's disease].
    Franken L, Noel G, Lhoas JP, Meyers C, Noel P, Ectors M.
    Brux Med; 1972 Dec; 52(12):851-60. PubMed ID: 4575350
    [No Abstract] [Full Text] [Related]

  • 6. [Longtime study on the effects of L-dopa therapy in parkinsonism].
    Fischer PA, Schneider E, Jacobi P, Maxion H.
    Nervenarzt; 1973 Mar; 44(3):128-35. PubMed ID: 4572536
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Long-term treatment of Parkinsonism with L-dopa].
    Presthus J, Holmsen R.
    Tidsskr Nor Laegeforen; 1972 Nov 30; 92(33):2262-6. PubMed ID: 4630916
    [No Abstract] [Full Text] [Related]

  • 9. L-Dopa (L-3,4-dihydroxyphenylanine)--its clinical effects in parkinsonism.
    Yahr MD, Duvoisin RC, Hoehn MM, Schear MJ, Barrett RE.
    Trans Am Neurol Assoc; 1968 Nov 30; 93():56-63. PubMed ID: 4885744
    [No Abstract] [Full Text] [Related]

  • 10. L-dopa for parkinsonism.
    Reveno WS, Bauer RB, Rosenbaum H.
    Geriatrics; 1973 Jan 30; 28(1):86-8. PubMed ID: 4683093
    [No Abstract] [Full Text] [Related]

  • 11. [Efficacy and side effects of L-dopa in patients with Parkinson's syndrome].
    Lombardo L.
    Arch Invest Med (Mex); 1973 Jan 30; 4(3):215-24. PubMed ID: 4784173
    [No Abstract] [Full Text] [Related]

  • 12. Mood changes during l-dopa therapy.
    Anumonye A.
    J Med Soc N J; 1972 Feb 30; 69(2):139-43. PubMed ID: 4550284
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Treatment of Parkinsonism with L-dopa--with special reference to clinical effects, side effects and urinary metabolites of catecholamines].
    Uono M, Tanabe H, Yano Y, Nakao K.
    No To Shinkei; 1970 Sep 30; 22(9):1091-101. PubMed ID: 5536082
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Parkinsonism, vitiligo and L-dopa. Contribution to the study of the embryological and functional correlation between nervous system and skin].
    Iparraguirre CE.
    Rev Neuropsiquiatr; 1971 Dec 30; 34(4):274-81. PubMed ID: 5164553
    [No Abstract] [Full Text] [Related]

  • 17. [Serum gonadotropic level under the medication L-dopa].
    Janzik HH, Heller S.
    Arzneimittelforschung; 1974 Aug 30; 24(8):1084-5. PubMed ID: 4479602
    [No Abstract] [Full Text] [Related]

  • 18. [L-DOPA therapy of parkinsonism].
    Refsum S.
    Nord Med; 1969 May 01; 81(18):570-1. PubMed ID: 5768311
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [L-dopa and parkinsonism. A preliminary report].
    Pakkenberg H.
    Ugeskr Laeger; 1969 May 29; 131(22):959-60. PubMed ID: 5793628
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.